{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T22:43:53Z","timestamp":1760481833318,"version":"build-2065373602"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Lynch syndrome (LS) is an autosomal dominant disorder caused by germline mutations in mismatch repair (MMR) genes or EpCAM, leading to various cancers, particularly colorectal cancer (CRC). EpCAM mutations account for approximately 1%\u20133% of LS cases, while co-mutations involving EpCAM and MSH2 are exceedingly rare. To date, co-mutations of EpCAM, MSH2 and PMS2 have not been reported in the literature.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Presentation<\/jats:title><jats:p>This case reports a 25-year-old male diagnosed with adenocarcinoma of the ascending colon. His family history revealed eight cancer cases among 30 relatives across five generations, consistent with LS. Immunohistochemistry (IHC) of the tumor showed loss of EpCAM, MSH2 and MSH6 protein expression. Genetic testing of the proband\u2019s tumor identified a novel large deletion affecting EpCAM exons 8-9 and MSH2 exons 1\u201316, likely pathogenic mutations disrupting MMR gene function. Whole-exome sequencing (WES) of peripheral blood from six family members, including the proband and his son, revealed co-mutations of EpCAM (c.344T&amp;gt;C), MSH2 (c.2744A&amp;gt;G), PMS2 (c.1408\u00a0C&amp;gt;T) and APC (c.5465T&amp;gt;A). Although public databases suggested these variants are benign or of uncertain significance (VUS), several <jats:italic>in silico<\/jats:italic> prediction tools and prior literature suggest potential pathogenicity. Notably, WES of the proband\u2019s son\u2019s peripheral blood also detected the same large deletions in EpCAM and MSH2, implying the presence of germline mosaicism and a possibly heightened early-onset cancer risk.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This rare subtype of LS emphasizes the need for comprehensive genetic screening and may inform future strategies for early detection and management in LS families. Further studies are required to confirm these findings.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fgene.2025.1667899","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T22:10:17Z","timestamp":1760479817000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A rare subtype of lynch syndrome familial with co-mutation of EpCAM c.344T&gt;C, MSH2 c.2744A&gt;G, PMS2 c.1408C&gt;T and APC c.5465T&gt;A, case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Guiyu","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuidong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqian","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengyue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianshuo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/s41431-020-0689-6","article-title":"Molecular tumor testing in patients with Lynch-like syndrome reveals a de novo mosaic variant of a mismatch repair gene transmitted to offspring","volume":"28","author":"Guillerm","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.6004\/jnccn.2019.0044","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: colorectal, version 2.2019","volume":"17","author":"Gupta","year":"2019","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"B3","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.1007\/s11033-012-1560-9","article-title":"Functional polymorphism in the EpCAM gene is associated with occurrence and advanced disease status of cervical cancer in Chinese population","volume":"39","author":"Hu","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"856452","DOI":"10.3389\/fonc.2022.856452","article-title":"Lynch syndrome-associated endometrial cancer with combined EPCAM-MSH2 deletion: a case report","volume":"12","author":"Huang","year":"2022","journal-title":"Front. Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.cgh.2020.02.049","article-title":"Mosaicism in patients with colorectal cancer or polyposis syndromes: a systematic review","volume":"18","author":"Jansen","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10549-010-1094-6","article-title":"A non-synonymous polymorphism Thr115Met in the EpCAM gene is associated with an increased risk of breast cancer in Chinese population","volume":"126","author":"Jiang","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"B7","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1470-2045(10)70265-5","article-title":"Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study","volume":"12","author":"Kempers","year":"2011","journal-title":"Lancet Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/s0092-8674(00)81333-1","article-title":"Lessons from hereditary colorectal cancer","volume":"87","author":"Kinzler","year":"1996","journal-title":"CELL"},{"key":"B10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/humu.21446","article-title":"Recurrence and variability of germline EPCAM deletions in Lynch syndrome","volume":"32","author":"Kuiper","year":"2011","journal-title":"Hum. Mutat."},{"key":"B11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/cr.2007.115","article-title":"Mechanisms and functions of DNA mismatch repair","volume":"18","author":"Li","year":"2008","journal-title":"CELL Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/jclinpath-2012-201376","article-title":"Colorectal cancer in a 9-year-old due to combined EPCAM and MSH2 germline mutations: case report of a unique genotype and immunophenotype","volume":"66","author":"Li-Chang","year":"2013","journal-title":"J. Clin. Pathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/pde.15878","article-title":"Constitutional mismatch repair deficiency: scoping review of a cancer-predisposition syndrome with distinctive cutaneous findings","volume":"42","author":"Mar","year":"2025","journal-title":"Pediatr. Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1056\/NEJMra0804588","article-title":"Molecular origins of cancer: molecular basis of colorectal cancer","volume":"361","author":"Markowitz","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/gcc.20678","article-title":"Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome","volume":"48","author":"Niessen","year":"2009","journal-title":"Genes Chromosom. Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1146\/annurev-physiol-061121-040048","article-title":"Somatic mosaicism in biology and disease","volume":"84","author":"Ogawa","year":"2022","journal-title":"Annu. Rev. Physiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ajmg.a.32620","article-title":"Somatic mosaicism in a patient with Lynch syndrome","author":"Pastrello","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00384-019-03414-y","article-title":"Identification of a novel large EPCAM-MSH2 duplication, concurrently with LOHs in chromosome 20 and X, in a family with Lynch syndrome","volume":"34","author":"Pirini","year":"2019","journal-title":"Int. J. Colorectal Dis."},{"key":"B19","unstructured":"Prospective Lynch syndrome database\n          \n          \n          2025"},{"key":"B20","first-page":"2922","article-title":"MSH2 deficiency contributes to accelerated APC-Mediated intestinal tumorigenesis","volume":"56","author":"Reitmair","year":"1996","journal-title":"Cancer Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"7295","DOI":"10.2147\/OTT.S167645","article-title":"Evidence of response to pembrolizumab in a patient with lynch syndrome-related metastatic Colon cancer","volume":"11","author":"Salman","year":"2018","journal-title":"Onco Targets Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1186\/s12885-021-08239-z","article-title":"Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion","volume":"21","author":"Sankpal","year":"2021","journal-title":"BMC Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/his.13104","article-title":"Cytoplasmic MSH2 immunoreactivity in a patient with Lynch syndrome with an EPCAM-MSH2 fusion","volume":"70","author":"Sekine","year":"2017","journal-title":"Histopathology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1590\/S1516-31802009000100010","article-title":"Mismatch repair genes in Lynch syndrome: a review","volume":"127","author":"Silva","year":"2009","journal-title":"Sao Paulo Med. J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1053\/j.gastro.2009.07.039","article-title":"Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome","volume":"137","author":"Stoffel","year":"2009","journal-title":"Gastroenterology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1093\/carcin\/bgn082","article-title":"Modification of the associations between lifestyle, dietary factors and colorectal cancer risk by APC variants","volume":"29","author":"Theodoratou","year":"2008","journal-title":"Carcinogenesis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/ene.12647","article-title":"Glioblastomas, astrocytomas and oligodendrogliomas linked to Lynch syndrome","volume":"22","author":"Therkildsen","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/qjmed\/hcv137","article-title":"Lynch syndrome in the 21st century: clinical perspectives","volume":"109","author":"Tiwari","year":"2016","journal-title":"QJM"},{"key":"B30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/jmg.2007.048991","article-title":"Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)","volume":"44","author":"Vasen","year":"2007","journal-title":"J. Med. Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1053\/j.gastro.2010.02.053","article-title":"One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome","volume":"138","author":"Vasen","year":"2010","journal-title":"Gastroenterology"},{"key":"B32","first-page":"14","article-title":"Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition","volume":"36","author":"Wallis","year":"1999","journal-title":"J. Med. Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3324\/haematol.2009.021626","article-title":"Constitutional mismatch repair-deficiency syndrome","volume":"95","author":"Wimmer","year":"2010","journal-title":"Haematologica"},{"key":"B34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/jmedgenet-2014-102284","article-title":"Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'care for CMMRD' (C4CMMRD)","volume":"51","author":"Wimmer","year":"2014","journal-title":"J. Med. Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/cas.12318","article-title":"Polymorphisms of EpCAM gene and prognosis for non-small-cell lung cancer in han Chinese","volume":"105","author":"Yang","year":"2014","journal-title":"Cancer Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1200\/JCO.2016.71.0012","article-title":"Cancer susceptibility gene mutations in individuals with colorectal cancer","volume":"35","author":"Yurgelun","year":"2017","journal-title":"J. Clin. Oncol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1667899\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T22:10:19Z","timestamp":1760479819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1667899\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":36,"alternative-id":["10.3389\/fgene.2025.1667899"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1667899","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"article-number":"1667899"}}